09.11.2011 • NewsPeopleAlbemarleCelanese

Albemarle Executive Chairman Mark Rohr to Take Over at Celanese

Celanese Chairman and CEO David N. Weidman will be retiring in April 2012.
Celanese Chairman and CEO David N. Weidman will be retiring in April 2012.

Celanese Chairman and CEO David N. Weidman will be retiring in April 2012. The company's board of directors has appointed Mark C. Rohr as his successor. Rohr is currently the executive chairman of Albemarle's board. He will step down from that position on Feb. 1.

Weidman joined Celanese in 2000. In 2002 he was named chief operating officer and was named chief executive officer in 2004 following the company's move from Germany to the United States. Weidman led the company through its initial public offering in January 2005 and was elected chairman of the board in 2007.

Company

Celanese

Brüningstr.
Frankfurt
Germany

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.